238 per cent returns in this high ROE & high ROCE multibagger stock: Board announces 1:1 bonus shares! 238 per cent returns in this high ROE & high ROCE multibagger stock: Board announces 1:1 bonus shares! The shares of the company have a ROE of 53.2 per cent and a ROCE of 36.7 per cent. Kiran Shroff / Thursday, September 7, 2023 / Article rating: 3.5 The company has a market cap of Rs 348 crore. According to the annual results, the net sales increased by 15.15 per cent to Rs 114 crore and net profit increased by 42.86 per cent to Rs 10 crore in FY23 over FY22.
200 per cent returns in just six months: Board announced bonus shares and annual results! 200 per cent returns in just six months: Board announced bonus shares and annual results! The company has reported 55 per cent jump in net profit of the company in FY23. Praveenkumar Yadav / Saturday, September 2, 2023 / Article rating: 4.0 The company has reported 55 per cent jump in net profit of the company in FY23.
Micro-cap pharma stock announces 1:1 bonus share for the first time ever; don’t miss out on the record date! Micro-cap pharma stock announces 1:1 bonus share for the first time ever; don’t miss out on the record date! Company ranks among the top 5 companies in India for providing the most extensive range of Iodine derivatives in the market Karan Dsij / Wednesday, August 2, 2023 / Article rating: 4.0 The company reported a net profit of Rs. 9.49 crore for FY23, exhibiting a remarkable year-on-year growth of 55.4 per cent when compared to the net profit of Rs. 6.10 crore achieved in FY22
High ROE & high ROCE multibagger stock; Board likely to announce bonus shares! High ROE & high ROCE multibagger stock; Board likely to announce bonus shares! The stock gave multibagger returns of 102 per cent in just 3 months. Kiran Shroff / Sunday, July 23, 2023 / Article rating: 3.7 The company has a market cap of Rs 205 crore. According to the annual results, the net sales increased by 15.15 per cent to Rs 114 crore and net profit increased by 42.86 per cent to Rs 10 crore in FY23 over FY22.